Pharmacokinetics, dose strategies, calorie planning, and the physiology behind why the tracker is built the way it is. For people on tirzepatide, semaglutide, and compounded peptides who want to understand what's actually happening, not just follow a regimen.
An educational overview of nausea, reflux, sulfur burps, constipation, diarrhea, and fatigue on Ozempic, Wegovy, Mounjaro, and Zepbound — what causes them, what users commonly try, and when to call a prescriber.
Same peptide, three deliveries. The practical differences between Ozempic, Wegovy, and compounded semaglutide — and why the tracker treats them identically.
Nausea patterns on tirzepatide and semaglutide are predictable. Knowing when the peak lands (and when it goes away) is the difference between white-knuckling it and planning around it.
Why daily calorie targets fail on Ozempic, Wegovy, Mounjaro, and Zepbound — and how a 7-day rolling window fixes the problem without asking you to overeat.
A 5-day half-life sounds simple until you're on your fourth weekly injection and your active blood level is ~2.5× your dose. The math behind why Mounjaro and Zepbound keep ramping for about a month.